By a News Reporter-Staff News Editor at Clinical Trials Week -- Current study results on Dementia and Mental Illness have been published. According to news reporting from Madrid, Spain, by NewsRx journalists, research stated, "We conducted a pilot, randomized, controlled trial to mainly investigate the feasibility, safety, and short-term motor effects of brain stimulation with radio electric asymmetric conveyer (REAC) technology in patients with advanced Alzheimer's disease (AD) who also experience some gait dysfunction. Neuropostural optimization (NPO) or sham protocol was administered to 31 nursing home patients (mean [SD] age 84.7 [7.0], 77.4% female, 6.5% moderate dementia, 51.6% moderately severe dementia, and 41.9% severe dementia)."
The news correspondents obtained a quote from the research from the Carlos III Institute of Health, "Motor, cognitive, functional, and behavioral measures were conducted at baseline (T1), immediately after treatment (T2), and 1-3 weeks after treatment (T3). There was transitory dysfunction in axial movements at T2 in the experimental group with no other differences between the experimental group and the control group in the planned analyses. However, after reanalysis of data based on outcome, improvement in capacity of walking was observed at T3 in the experimental group (p
According to the news reporters, the research concluded: "These results warrant further research with NPO and other REAC protocols to improve motor deterioration in AD."
For more information on this research see: Motor effects of REAC in advanced Alzheimer's disease: results from a pilot trial. Journal of Alzheimer's Disease, 2013;36(2):297-302. Journal of Alzheimer's Disease can be contacted at: IOS Press, Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands (see also Dementia and Mental Illness).
Our news journalists report that additional information may be obtained by contacting J. Olazaran, Alzheimer Disease Research Unit, Alzheimer Center Reina Sofia Foundation, CIEN Foundation, Carlos III Institute of Health, Madrid, Spain. Additional authors for this research include B. Gonzalez, J. Lopez-Alvarez, A. Castagna, E. Osa-Ruiz, V. Herrero-Cano, L. Aguera-Ortiz, S. Rinaldi and P. Martinez-Martin.
Publisher contact information for the Journal of Alzheimer's Disease is: IOS Press, Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands.
Keywords for this news article include: Spain, Madrid, Europe, Treatment, Tauopathies, Brain Diseases, Alzheimer Disease, Neurodegenerative Diseases, Clinical Trials and Studies, Dementia and Mental Illness, Central Nervous System Diseases.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC